Ablation Clinical Trials

80 recruitingLast updated: June 17, 2026

There are 80 actively recruiting ablation clinical trials across 28 countries. Studies span Not Applicable, Phase 2, Phase 4. Top locations include Beijing, Beijing Municipality, China, Guangzhou, Guangdong, China, Paris, France. Updated daily from ClinicalTrials.gov.


Ablation Trials at a Glance

80 actively recruiting trials for ablation are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 49 trials, with the heaviest enrollment activity in Beijing, Guangzhou, and Paris. Lead sponsors running ablation studies include Sun Yat-sen University, Pulse Biosciences, Inc., and M.D. Anderson Cancer Center.

Browse ablation trials by phase

Treatments under study

About Ablation Clinical Trials

Looking for clinical trials for Ablation? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ablation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ablation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 80 trials

Recruiting
Not Applicable

Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension

AdrenalectomyPrimary Aldosteronism Due to Conn AdenomaRadiofrequency Ablation Treatment
University Hospital, Toulouse134 enrolled1 locationNCT07470580
Recruiting
Not Applicable

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

StrokeFrailtyAtrial Fibrillation (AF)+4 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07441382
Recruiting
Not Applicable

Monopolar Basivertebral Nerve Ablation for Axial Low Back Pain

Chronic Back PainBasivertebral Nerve Ablation
EPC Education s.r.o.100 enrolled3 locationsNCT07559890
Recruiting

EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

Pancreatic LesionGastrointestinal LesionsMicrowave Ablation+2 more
West Virginia University50 enrolled1 locationNCT07625189
Recruiting

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

Thyroid NodulesPulsed Field Ablation
M.D. Anderson Cancer Center30 enrolled1 locationNCT07226804
Recruiting
Not Applicable

Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)

Atrial Fibrillation (AF)Atrial Fibrillation AblationPulsed Field Ablation+2 more
China National Center for Cardiovascular Diseases1,574 enrolled1 locationNCT07601763
Recruiting
Not Applicable

NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

Atrial Fibrillation (Paroxysmal)Cardiac ArrhythmiaCardiac Ablation
Pulse Biosciences, Inc.215 enrolled1 locationNCT07018596
Recruiting
Not Applicable

CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation

Atrial Fibrillation (Paroxysmal)Cardiac ArrhythmiaCardiac Ablation
Pulse Biosciences, Inc.60 enrolled3 locationsNCT06696170
Recruiting
Not Applicable

Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation

Atrial FibrillationCatheter AblationRadiofrequency Catheter Ablation
Ottawa Heart Institute Research Corporation556 enrolled2 locationsNCT04823299
Recruiting
Not Applicable

Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)

Liver AblationHepatic
M.D. Anderson Cancer Center50 enrolled1 locationNCT05361551
Recruiting
Not Applicable

Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

AblationThyroid NoduleThyroid Goiter
Pulse Biosciences, Inc.100 enrolled3 locationsNCT07287176
Recruiting
Not Applicable

Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors

Endoscopic Ultrasound-Guided Radiofrequency AblationPancreatic Neuroendocrine Tumors (pNET)Pancreatic Cystic Neoplasms
Institute for Clinical and Experimental Medicine50 enrolled1 locationNCT07536087
Recruiting

Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation

Spine MetastasesRadiofrequency AblationBone Cancer Metastatic+1 more
National and Kapodistrian University of Athens16 enrolled1 locationNCT06716294
Recruiting

Impact of RFA on Esophageal Distensibility and Mucosal Impedance

Barrett EsophagusRadiofrequency AblationDysplastic Barrett's Esophagus
Mayo Clinic10 enrolled1 locationNCT07126535
Recruiting
Not Applicable

Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation

Ventricular TachycardiaVentricular ArrhythmiaAblation of Arrhythmias+1 more
Insel Gruppe AG, University Hospital Bern70 enrolled2 locationsNCT07201506
Recruiting
Not Applicable

Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Symptoms and High Stroke Risk

ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATIONPFA Ablation and LAAC Procedures
Sir Run Run Shaw Hospital50 enrolled1 locationNCT07453940
Recruiting
Not Applicable

Ablation Compare With Surgery for Early Breast Cancer

Breast CancerAblationEarly Stage+1 more
Peking University People's Hospital264 enrolled1 locationNCT07484087
Recruiting
Not Applicable

Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters

Atrial Fibrillation (AF)Atrial Fibrillation AblationPulsed Field Ablation
Cardiocentro Ticino58 enrolled1 locationNCT07130773
Recruiting

A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation

Atrial FibrillationPulsed Field AblationFARAPULSE
Boston Scientific Corporation500 enrolled32 locationsNCT06808217
Recruiting
Not Applicable

Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

Atrial Fibrillation (AF)Catheter AblationAtrial Functional Mitral Regurgitation
Beijing Anzhen Hospital146 enrolled17 locationsNCT06883864